News & Media

Delhi-based biotechnology startup introduces cutting-edge AI-powered genomics diagnostics platform developed through rigorous research and clinical trials in collaboration with AIIMS, New Delhi. The platform enables early disease detection and personalized treatment plans.

Bioheaven360 Genotec secures 1 crore funding from Digital Futurists Angel Network (DFAN) to accelerate growth and expand its AI-driven genomics diagnostic platform for early disease detection.

Revolutionary AI-powered genomics diagnostics platform designed to enable early disease detection and personalized treatment plans, marking a significant shift from reactive to proactive healthcare.

Cutting-edge AI-powered genomics diagnostics platform for early disease detection and personalized healthcare solutions developed in collaboration with leading medical institutions.

Delhi-based biotechnology company launches AI-powered genomics diagnostic platform developed through research and clinical trials, enabling early disease detection decades before symptoms appear.

Bioheaven360's research team focuses on identifying novel molecular markers for predictive risk assessment and understanding how gene function changes with age for better healthcare outcomes.

Watch our video coverage showcasing Bioheaven360's AI-driven genomics diagnostic platform and its impact on early disease detection and personalized healthcare.

Exploring the journey from DNA discovery to precision medicine applications, highlighting how genomics is revolutionizing personalized healthcare.

Social media coverage and discussion about Bioheaven360's innovations in genomics and healthcare technology.

Live video coverage and discussion about Bioheaven360's AI-driven genomics diagnostic platform and its impact on healthcare.

Featured coverage in FII's Bharat News publication highlighting Bioheaven360's contributions to biotechnology and healthcare innovation.